LEISH-PED: Study on Leishmaniasis in Children

Recruiting Observational Study
Leishmania Infantum Disease Leishmaniasis, Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 17
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Meyer Children's Hospital IRCCS · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Leishmaniasis is an infection caused by Leishmania parasites. In children, it can affect the skin or internal organs. Diagnosis may be delayed because the signs and symptoms can be similar to those of other conditions. Delayed diagnosis or treatment may lead to worse outcomes. Treatment approaches, especially for cutaneous leishmaniasis, may also vary across centers. This study aims to improve kno…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients younger than 18 years of age at the time of diagnosis * Diagnosis of human leishmaniasis according to World Health Organization (WHO) criteria * Written informed consent signed by parents or legal guardians; patient assent when applicable Exclusion Criteria: * Patie…
Contacts

Elisabetta Venturini, MD,Phd

+39 3490920901

elisabetta.venturini@meyer.it

CONTACT